Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bangladesh Reports Nearly All Children Vaccinated To End Polio (Bangladesh)

This article was originally published in PharmAsia News

Executive Summary

Bangladesh has completed its nationwide polio vaccination program aimed at giving millions of children their second shots of the drug, health officials said. The country's Health Ministry said 25 million children were given shots and the disease should now be wiped out. Bangladesh had been declared polio-free in 2000, but the disease re-emerged in March 2006, when 18 children were infected, most in a region that borders India where there are about 500 cases. A ministry adviser said nearly all targeted children were vaccinated in Bangladesh. (Click here for more) "Bangladesh Completes Polio Vaccination Drive" Reuters (U.K.) (12/8/07)

Bangladesh has completed its nationwide polio vaccination program aimed at giving millions of children their second shots of the drug, health officials said. The country's Health Ministry said 25 million children were given shots and the disease should now be wiped out. Bangladesh had been declared polio-free in 2000, but the disease re-emerged in March 2006, when 18 children were infected, most in a region that borders India where there are about 500 cases. A ministry adviser said nearly all targeted children were vaccinated in Bangladesh. (Click here for more)

"Bangladesh Completes Polio Vaccination Drive"
Reuters (U.K.) (12/8/07)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC065844

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel